Bone Void Filler for overseas market
ReBOSSIS
The world’s first cotton-shaped artificial bone filler with bioactivity evidenced by ISO23317 that went on sale in the United States in February 2015. “It is characterized by high bone shape performance, good bioabsorbability, and ease of processing.”
The number of cases of trauma and orthopedic surgery in the spinal area has already exceeded 8,000 (as of August 2021) and has attracted the attention of many orthopedic surgeons.
*Bioactivity has not been evaluated in clinical trials.
For more information
The number of cases of trauma and orthopedic surgery in the spinal area has already exceeded 8,000 (as of August 2021) and has attracted the attention of many orthopedic surgeons.
*Bioactivity has not been evaluated in clinical trials.
ReBOSSIS QDS
Combination of ReBOSSIS and syringe
“Pursuing ease of use and minimal invasiveness”
For more information
“Pursuing ease of use and minimal invasiveness”
Bone Void Filler for Japanese market
ReBOSSIS-J
A newcomer to the ReBOSSIS family.
ReBOSSIS-J is a cotton-shaped bone filler that has been improved for the Japanese market based on ReBOSSIS sold in the United States.
On March 29, 2021, we obtained manufacturing and marketing approval in Japan for Class IV medical devices. Started sales in September 2021.
* ReBOSSIS-J is marketed only in Japan with authority approval.
For more information
ReBOSSIS-J is a cotton-shaped bone filler that has been improved for the Japanese market based on ReBOSSIS sold in the United States.
On March 29, 2021, we obtained manufacturing and marketing approval in Japan for Class IV medical devices. Started sales in September 2021.
* ReBOSSIS-J is marketed only in Japan with authority approval.
Cell Culture Materials
Stem Cell Culture/Extract Sheet
For More Efficiency & Cost Reduction
“Best Fruit of our Bioabsorbable Fiber Technology.”
For more information
“Best Fruit of our Bioabsorbable Fiber Technology.”
